---
title: "En-Bloc and Total Capsulectomy: What the Evidence Says About Breast Implant Removal"
url: https://drturner.com.au/blogs/patient-safety-advisory-breast-implant-removal-and-capsulectomy/
date: 2023-06-19
modified: 2026-07-30
author: "Dr Scott J Turner"
description: "Dr Scott J Turner | Specialist Plastic Surgeon (FRACS) Key Takeaways The terms used around explant are frequently used loosely. Implant removal, partial capsulectomy, total capsulectomy, intact capsulectomy and en-bloc..."
categories:
  - "Breast Augmentation"
  - "Breast Implants"
image: https://drturner.com.au/wp-content/uploads/2024/04/blogplaceholder-img.svg
word_count: 2441
---

# En-Bloc and Total Capsulectomy: What the Evidence Says About Breast Implant Removal

*[Dr Scott J Turner](https://drturner.com.au/dr-scott-turner-sydney-plastic-surgeon/) | Specialist Plastic Surgeon (FRACS)*

> **Key Takeaways**
>
>
>
>
> - The terms used around explant are frequently used loosely. Implant removal, partial capsulectomy, total capsulectomy, intact capsulectomy and en-bloc resection all mean different things, and clinics sometimes use the most clinical-sounding one regardless of what is performed.
> - "En-bloc" is an oncology term for removing a tumour with surrounding tissue as one intact specimen. In routine explant it is often used to mean intact capsulectomy, which is a different thing.
> - The current evidence does not establish that en-bloc capsulectomy produces better symptom improvement than partial capsulectomy for breast implant illness. Both have shown improvement.
> - Complete intact capsule removal is not always anatomically achievable, because the capsule can adhere to the ribs, chest muscle and lung lining, and safety takes priority over technique.
> - Good practice includes a medical workup before surgery to identify or exclude other treatable causes of systemic symptoms, rather than assuming the implants are the cause.
> - The choice of approach should be individualised to capsule condition, implant integrity, patient preference and what is safe to attempt, not applied as a single technique to every patient.
Few topics in breast surgery have drifted as far between marketing language and clinical evidence as en-bloc capsulectomy. Across enough clinic websites, "true en-bloc" is promoted as a specific technique, sometimes positioned as the only way to address breast implant illness. The clinical reality is more nuanced: the evidence does not establish en-bloc as better than partial capsulectomy for symptom improvement, the term has been borrowed from oncology in ways that are not always accurate, and what is actually achieved during surgery varies between providers regardless of the label on the booking.

This guide is for anyone considering implant removal who wants a straight account of what the clinical and research consensus actually says about capsulectomy technique and explant outcomes. The surgical pathway itself is covered on the [breast implant revision and removal](https://drturner.com.au/procedures/breast-body/breast-implant-revision/) page; this article covers the technique and the evidence. For the practical recovery side see [recovery after breast implant removal](https://drturner.com.au/blogs/recovery-after-breast-implant-removal-procedure/), and for the symptom-and-evidence side see the guide to [breast implant illness](https://drturner.com.au/blogs/latest-update-on-breast-implant-illness-symptoms-and-treatment/).

## Definitions: what each term actually means

Much of the confusion around explant comes from terms used loosely. What each means in surgical practice:

- **Implant removal alone:** the implants are removed through the original incision, the pocket is cleaned, and the surrounding capsule is left in place to reabsorb over time.
- **Partial capsulectomy:** the implants are removed along with a portion of the capsule. Capsule adherent to underlying structures, or showing no sign of pathology, is left in place.
- **Total capsulectomy:** the entire capsule is removed, but not necessarily as a single intact specimen.
- **Intact capsulectomy:** the entire capsule is removed in one piece, with the implant still inside it.
- **En-bloc resection:** an oncology term for removing a tumour along with surrounding tissue as a single intact specimen. Appropriate in cancer surgery, and often misapplied in explant marketing to mean intact capsulectomy.

These distinctions matter because patients, surgeons and oncologists often use the same words to mean different things, and clinics sometimes use the most clinical-sounding term regardless of what is actually performed.

## The symptoms that drive the conversation

Some patients with implants experience a cluster of systemic symptoms they attribute to the implants, most commonly described as breast implant illness. Some clinical bodies prefer the more neutral "systemic symptoms associated with breast implants," because it does not imply a causation that has not been definitively proven. The symptom list is broad, with over 100 reported in the literature and no single pattern that defines a diagnostic test; the most commonly reported include fatigue, cognitive difficulty, joint and muscle pain, skin changes and a general sense of being unwell. Both the TGA in Australia and the FDA in the United States now include patient information about systemic symptoms in their materials on breast implants. The evidence base is covered in full in the dedicated [breast implant illness guide](https://drturner.com.au/blogs/latest-update-on-breast-implant-illness-symptoms-and-treatment/).

## What the evidence currently supports

The evidence on explant outcomes has developed considerably over recent years. The areas of reasonable agreement relate to reported symptoms and outcomes after removal rather than to a unified causal mechanism:

- Patients have reported these symptoms with implants of all types, across saline and silicone, smooth and textured surfaces, and all manufacturers. No single implant brand or type accounts for the syndrome.
- Some patients experience meaningful symptom improvement after removal. The proportion who improve, the degree, and the timing all vary substantially between patients.
- Research comparing patients with self-described breast implant illness to control groups has found the symptomatic group reported more symptoms at baseline and experienced rapid improvement after removal, without significant differences in biospecimens between the groups.
- The evidence does not establish that any specific technique, en-bloc versus partial capsulectomy versus removal alone, produces meaningfully better symptom improvement.
- The mechanism of improvement is not fully understood, and improvement after explant, while real and clinically meaningful, does not by itself prove the implants were the sole cause.

## The en-bloc terminology debate

The term en-bloc originates in oncology, where it describes removing a tumour with surrounding tissue as a single intact specimen to prevent spread of tumour cells. It has a specific clinical purpose in cancer surgery. Patients often use it to mean intact capsule removal, surgeons sometimes use it loosely for total capsulectomy of any kind, and some clinics use it as a marketing claim implying a clinical necessity the evidence does not support.

En-bloc as a patient preference is a separate matter from en-bloc as a marketing claim. Some patients genuinely prefer intact capsulectomy, particularly with concerns about breast implant illness or a known silicone rupture where they want maximum reassurance about containment, and that is a reasonable personal preference. Where it is the plan, every effort is made to remove the entire capsule. The honest qualification is that complete intact removal is not always anatomically achievable: the capsule can adhere to underlying structures including the ribs, the chest muscle and the lung lining, and forcing complete removal in those areas can create unnecessary risk. Safety takes priority over technique. For most explant cases done for symptom concerns, partial capsulectomy is clinically sufficient, and the choice between approaches should be individualised to capsule thickness, implant integrity, patient preference and the technical feasibility of complete removal in a given anatomy.

## When different approaches may be appropriate

The right approach depends on the indication for surgery, imaging findings, and what is safe to attempt during the procedure. As a general guide:

- **Implant removal alone** can suit patients with intact implants, no significant contracture and no other capsular pathology, with the capsule left to reabsorb over time.
- **Partial capsulectomy** is the most commonly used approach across symptom-driven explant, mild contracture and routine removal, taking the capsule where pathology exists or where removal is straightforward and leaving capsule adherent to underlying structures.
- **Total capsulectomy** may be considered for significant contracture, calcification, or capsule thickening that the patient or surgeon wants fully removed. The role of capsulectomy in contracture specifically is covered in the [capsular contracture guide](https://drturner.com.au/blogs/what-is-capsular-contracture-and-how-can-it-be-treated/).
- **Intact capsulectomy** is sometimes attempted by patient preference, or where confirmed silicone rupture means keeping the capsule intact reduces spread during removal.
- **True oncologic en-bloc resection** is reserved for confirmed or suspected malignancy such as BIA-ALCL, where intact removal of surrounding tissue is part of cancer treatment; that condition is covered in the [BIA-ALCL guide](https://drturner.com.au/blogs/bia-alcl-symptoms-diagnosis-and-treatment-of-breast-implant-associated-lymphoma/).

A surgeon who can articulate why a specific approach suits your specific case is giving you better information than one who applies a single technique to every patient.

## Choosing a surgeon for explant

The relevant qualifications for explant are the same as for any breast surgery: Fellowship of the Royal Australasian College of Surgeons in Plastic Surgery, current AHPRA registration as a Specialist Plastic Surgeon, admitting rights at accredited hospitals, and membership of professional societies including the Australian Society of Plastic Surgeons. Surgical experience with removal is reasonable to ask about, and there is no recognised "explant expert" sub-specialty designation in Australia.

When evaluating a clinic, look for verifiable credentials and AHPRA registration, admitting rights at accredited private hospitals rather than day-only facilities, a consultation that involves measurement, examination, imaging review and a discussion of more than one surgical option, honest framing of the evidence including where it is uncertain, and a willingness to recommend medical workup before surgery rather than fast-tracking to theatre.

Be cautious of marketing that promotes a specific technique as the only correct approach, uses oncology terms like en-bloc prominently without acknowledging their specific meaning, promises symptom resolution after explant, presents breast implant illness as a clearly defined diagnosis with established criteria, discourages standard medical workup, or pressures a quick decision. These are evidence and consent considerations rather than criticisms of any individual provider, intended to give patients a framework for assessing claims. How to assess a surgeon more broadly is covered in the guide on [choosing a breast surgeon](https://drturner.com.au/blogs/best-breast-augmentation-surgeon-sydney/).

## What a properly conducted explant pathway looks like

Before surgery is considered, good practice typically includes a medical workup to look for alternative causes of systemic symptoms. This may involve blood tests for inflammatory markers, thyroid function, hormonal status and vitamin levels, and screening for autoimmune conditions, with assessment by a rheumatologist, endocrinologist or other specialist where appropriate. Many patients who present with concerns about breast implant illness have a different underlying cause that responds to other treatment, and identifying or excluding those before surgery is part of good clinical practice.

Imaging is appropriate where a complication is suspected. MRI is the most reliable test for detecting silent rupture in silicone implants, ultrasound can identify capsular issues and seromas, and routine mammographic screening should continue at the recommended interval. The preoperative pathway should include appropriate medical assessment, careful informed consent, and compliance with the current regulatory requirements for cosmetic surgery where they apply. The framework that applies depends on the indication: explant for a clearly medical reason such as confirmed rupture or contracture follows a standard surgical consultation pathway, while explant for purely personal reasons follows the cosmetic surgery framework introduced on 1 July 2023. Which applies to a given case is explained at consultation, and the funding side is covered in the guide to [Medicare and breast implant removal](https://drturner.com.au/blogs/will-medicare-cover-my-breast-implant-removal/).

The surgical conversation should cover what is actually planned. If partial capsulectomy is appropriate, it should be explained as the recommended approach for that situation rather than framed as a lesser version of en-bloc. If intact removal is being attempted, the patient should understand that complete removal is not always achievable and that anatomical and safety limits may prevent it.

## Honest pre-surgery counselling

A clinic that promises symptom resolution after explant is overstating what the evidence supports. The honest conversation sets realistic expectations: meaningful improvement is the most likely outcome for symptomatic patients, but it is not universal and the timing varies. Some see significant improvement within weeks, others partial improvement that builds over months, and a smaller proportion see no meaningful change. The mechanism, whether resolution of an immune response, removal of low-grade biofilm, other factors or some combination, is genuinely uncertain, and improvement can be a real and meaningful outcome even without a complete mechanistic explanation.

## Australian regulatory context

The TGA has cancelled the registration of specific breast implant products where significant risk was identified, and the macrotextured implants linked to BIA-ALCL have been largely withdrawn from the Australian market. The Australian Breast Device Registry tracks implant surgeries, complications and outcomes nationally, providing the data infrastructure for identifying patterns over time. If you have had implant surgery in Australia in recent years your data may be in the registry, and if you are considering explant and want your case to contribute to the evidence base, you can ask your surgeon whether your procedure will be entered.

## Frequently asked questions

**What is the difference between en-bloc and total capsulectomy?**

Total capsulectomy removes the entire capsule but not necessarily in one piece. En-bloc, more accurately called intact capsulectomy in this context, removes the entire capsule as a single specimen with the implant still inside. The terms are often used interchangeably in patient discussion and marketing, which adds to the confusion. The distinction matters because total capsulectomy is achievable in most cases where it is indicated, whereas complete intact removal is not always possible without putting underlying structures at risk.

**Does en-bloc capsulectomy produce better outcomes for breast implant illness?**

The current evidence does not establish en-bloc as more effective than partial capsulectomy for symptom improvement. Both have shown improvement in symptomatic patients. The choice should be individualised to capsule thickness, evidence of pathology, implant integrity, patient preference and the feasibility of complete removal in a given anatomy. Patient communities sometimes advocate strongly for en-bloc, but that position is not supported by the comparative evidence.

**What should I look for when choosing a surgeon for explant?**

Verifiable FRACS qualifications in plastic surgery, current AHPRA registration as a Specialist Plastic Surgeon, admitting rights at accredited private hospitals, and membership of professional societies. The consultation itself is informative: it should include measurement, examination, imaging review and a discussion of more than one option. A surgeon who explains why a particular approach suits your case, rather than recommending the same technique for everyone, is giving you better information. Marketing language about a specific technique is a poor basis for the choice.

**Will my symptoms improve after explant?**

This cannot be predicted with certainty for any individual. The evidence shows a substantial proportion of symptomatic patients experience meaningful improvement, some within weeks, others building over months, with a smaller proportion seeing no meaningful change. That uncertainty is part of an honest pre-surgery conversation, and a clinic that promises guaranteed resolution is overstating what the evidence supports.

**Do I need imaging and blood tests before considering explant?**

In most cases, yes. A thorough workup helps identify alternative explanations for systemic symptoms, including autoimmune conditions, thyroid dysfunction, hormonal change and others, many of which are treatable. Imaging is appropriate where a complication is suspected, with MRI the most reliable test for silent silicone rupture and ultrasound for capsular issues and seromas. Skipping this step risks proceeding to surgery for symptoms that have an alternative, treatable cause.

Dr Scott J Turner is a Specialist Plastic Surgeon (FRACS). A GP referral is required before an initial surgical consultation under the current Medical Board of Australia framework, and the framework that applies depends on whether removal is for a medical or a personal reason. If you are considering implant removal and want an evidence-based opinion on whether removal alone, partial capsulectomy or total capsulectomy suits your case, [contact the practice](https://drturner.com.au/contact-us/) to arrange a consultation.